ACIW
ACI Worldwide, Inc.
ACIW's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over ACIW overall, supported by stronger modeled upside and stronger valuation.
ACIW Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Strong | |
| Healthy |
ACIW's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
ACIW PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 20x | $31.80 | -48% |
| Forward | 22x | $61.26 | — |
| Fair | 29x | $46.13 | -25% |
| Current | 38x | $61.26 | — |
| Expensive | 46x | $74.84 | +22% |
Historical ranges are pointers, not guarantees.
ACIW's PE is in its fair range at 38x. If earnings grow as analysts expect, today's price would be 22x next year's earnings, in its cheap range.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over ACIW in the historical PE scenario, which offers more potential upside but is not a forecast.
ACIW Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
ACIW has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
ACIW Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.82 | +75% |
| Q3 2026 | $1.61 | -35% |
| Q2 2026 | $2.17 | -8.1% |
| Q1 2026 | $1.98 | -22% |
| Q4 2025 | $2.16 | +13% |
| Q3 2025 | $2.47 | +17% |
| Q2 2025 | $2.36 | +39% |
| Q1 2025 | $2.53 | +87% |
| Q4 2024 | $1.91 | +71% |
ACIW's earnings per share have fallen from their peak: $1.61 over the past year, against $2.53 in early 2025.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over ACIW on earnings, with more consistent year-over-year improvement.
ACIW Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $426.8M | -12% |
| Q2 2026 | $430.4M | +7.3% |
| Q1 2026 | $425.7M | +7.9% |
| Q4 2025 | $481.6M | +6.3% |
| Q3 2025 | $482.4M | +6.8% |
| Q2 2025 | $401.3M | +7.4% |
| Q1 2025 | $394.6M | +25% |
| Q4 2024 | $453M | -4.9% |
ACIW's revenue has held roughly level: $427M last quarter, down 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | -14 points |
| Q2 2026 | 10% | +1.7 points |
| Q1 2026 | 14% | -1.3 points |
| Q4 2025 | 23% | -4.4 points |
| Q3 2025 | 26% | -0.7 points |
| Q2 2025 | 8.7% | -5.7 points |
| Q1 2025 | 15% | +12 points |
| Q4 2024 | 27% | -9.2 points |
ACIW's operating margin was 12% last quarter, down 14 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over ACIW on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over ACIW on profitability, with a higher operating margin.
ACIW Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $116.3M | +67% |
| Q2 2026 | $63.9M | +34% |
| Q1 2026 | $61.2M | -19% |
| Q4 2025 | $116.6M | -2.5% |
| Q3 2025 | $69.6M | +38% |
| Q2 2025 | $47.6M | -11% |
| Q1 2025 | $76.1M | -37% |
| Q4 2024 | $119.5M | +41% |
ACIW's free cash flow has been positive every quarter for seven years: $358M over the past year, up 14% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over ACIW on cash flow, with more consistent year-over-year improvement.
ACIW Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -360K shares |
| 1 year | -2.5% | -2.6M shares |
| 3 years | -7% | -7.6M shares |
| 5 years | -15% | -17.2M shares |
| Available history | -15% | -17.3M shares |
ACIW has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $50M |
| Q2 2026 | $41.5M |
| Q1 2026 | $65.3M |
| Q4 2025 | $52.6M |
| Q3 2025 | $16.3M |
| Q2 2025 | $119.4M |
| Q1 2025 | $14.4M |
| Q4 2024 | — |
ACIW spent $209M buying back its own shares over the past year, up 40% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
ACIW Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.5x | Healthy |
| Q4 2025 | 1.5x | Healthy |
| Q3 2025 | 1.5x | Healthy |
| Q2 2025 | 1.6x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.7x | Healthy |
ACIW's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over ACIW on leverage, with a lower net debt burden relative to earnings.
ACIW Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 70.0 | Neutral |
| Stochastic | 77.4 | Neutral |
ACIW's weekly RSI is 70 (neutral) and its Stochastic is 77 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
ACIW PE vs Technology Sector
| Metric | ACIW | Sector median | Relative |
|---|---|---|---|
| PE | 38x | 28x | 37% above |
| PE % | 65 | 35 | 30 pts above |
ACIW is trading at 38x earnings, a 37% premium to the Technology sector's median of 28x.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over ACIW on valuation relative to its sector.
ACIW Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $54.6 | 12% above |
| 20 week MA | $54.4 | 13% above |
| 50 week MA | $47.9 | 28% above |
| 100 week MA | $48.7 | 26% above |
| 200 week MA | $40.8 | 50% above |
ACIW has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
ACIW Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.7 | $38.5 | +2.1% |
| 2021 | $38.5 | $34.9 | -9.4% |
| 2022 | $34.9 | $22.0 | -37% |
| 2023 | $22.0 | $30.6 | +39% |
| 2024 | $30.6 | $51.9 | +70% |
| 2025 | $51.9 | $48.7 | -6.1% |
| 2026 YTD | $48.7 | $61.3 | +26% |
ACIW has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.